−0.375 SEK
−30.36 M SEK
29.96 M SEK
52.58 M
About GLYCOREX TRANSPLANTATION B
Sector
Industry
CEO
Johan Laven
Website
Headquarters
Lund
Founded
1995
ISIN
SE0000524530
FIGI
BBG000DL2DC4
Glycorex Transplantation AB engages in the research and development in the field of organ transplantation. The firm focuses mainly in kidney transplant and also in liver, heart, pancreas, lung, and stem cell transplant. Its product allows transplantation regardless of the blood types of donors and recipients. The company was founded by Kurt Gösta Ingemar Nilsson in 1996 and is headquartered in Lund, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GTAB.B is 1.635 SEK — it has increased by 0.93% in the past 24 hours. Watch GLYCOREX TRANSPLANTATION B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange GLYCOREX TRANSPLANTATION B stocks are traded under the ticker GTAB.B.
GTAB.B stock has fallen by −4.39% compared to the previous week, the month change is a −13.26% fall, over the last year GLYCOREX TRANSPLANTATION B has showed a 22.01% increase.
GTAB.B reached its all-time high on Apr 29, 2020 with the price of 20.700 SEK, and its all-time low was 0.750 SEK and was reached on Apr 3, 2024. View more price dynamics on GTAB.B chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GTAB.B stock is 5.83% volatile and has beta coefficient of 0.55. Track GLYCOREX TRANSPLANTATION B stock price on the chart and check out the list of the most volatile stocks — is GLYCOREX TRANSPLANTATION B there?
Today GLYCOREX TRANSPLANTATION B has the market capitalization of 120.75 M, it has decreased by −4.16% over the last week.
Yes, you can track GLYCOREX TRANSPLANTATION B financials in yearly and quarterly reports right on TradingView.
GTAB.B net income for the last quarter is −2.22 M SEK, while the quarter before that showed −3.52 M SEK of net income which accounts for 36.87% change. Track more GLYCOREX TRANSPLANTATION B financial stats to get the full picture.
No, GTAB.B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLYCOREX TRANSPLANTATION B EBITDA is −7.07 M SEK, and current EBITDA margin is −86.42%. See more stats in GLYCOREX TRANSPLANTATION B financial statements.
Like other stocks, GTAB.B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLYCOREX TRANSPLANTATION B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLYCOREX TRANSPLANTATION B technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLYCOREX TRANSPLANTATION B stock shows the neutral signal. See more of GLYCOREX TRANSPLANTATION B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.